Comment on: development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms

Scand J Gastroenterol. 2023 Mar;58(3):319-320. doi: 10.1080/00365521.2022.2128694. Epub 2022 Oct 4.
No abstract available

MeSH terms

  • Humans
  • Neoplasm Staging
  • Neuroendocrine Tumors* / pathology
  • Nomograms
  • Pancreatic Neoplasms* / pathology
  • Prognosis
  • Survival Rate